Publication:
Pro-angiogenic potential of human chorion-derived stem cells: In vitro and in vivo evaluation

dc.Chemicals/CAScollagen, 9007-34-5; fibrin, 9001-31-4; fibroblast growth factor 2, 106096-93-9; laminin, 2408-79-9; matrigel, 119978-18-6; vasculotropin A, 489395-96-2; Collagen, 9007-34-5; Drug Combinations; Fibrin, 9001-31-4; Fibroblast Growth Factor 2, 103107-01-3; Laminin; Proteoglycans; Vascular Endothelial Growth Factor A; matrigel, 119978-18-6
dc.citedby4
dc.contributor.affiliationsFaculty of Medicine and Health Sciences
dc.contributor.affiliationsUniversiti Kebangsaan Malaysia (UKM)
dc.contributor.affiliationsUniversiti Sains Islam Malaysia (USIM)
dc.contributor.authorFariha M.-M.N.en_US
dc.contributor.authorChua K.-H.en_US
dc.contributor.authorTan G.-C.en_US
dc.contributor.authorLim Y.-H.en_US
dc.contributor.authorHayati A.-R.en_US
dc.date.accessioned2024-05-29T01:58:21Z
dc.date.available2024-05-29T01:58:21Z
dc.date.issued2013
dc.description.abstractHuman chorion-derived stem cells (hCDSC) were previously shown to demonstrate multipotent properties with promising angiogenic characteristics in monolayer-cell culture system. In our study, we investigated the angiogenic capability of hCDSC in 3-dimensional (3D) in vitro and in vivo angiogenic models for the purpose of future application in the treatment of ischaemic diseases. Human CDSC were evaluated for angiogenic and endogenic genes expressions by quantitative PCR. Growth factors secretions were quantified using ELISA. In vitro and in vivo vascular formations were evaluated by histological analysis and confocal microscopic imaging. PECAM-1+ and vWF+ vascular-like structures were observed in both in vitro and in vivo angiogenesis models. High secretions of VEGF and bFGF by hCDSC with increased expressions of angiogenic and endogenic genes suggested the possible angiogenic promoting mechanisms by hCDSC. The cooperation of hCDSC with HUVECS to generate vessel-like structures in our systems is an indication that there will be positive interactions of hCDSC with existing endothelial cells when injected into ischaemic tissues. Hence, hCDSC is suggested as the novel approach in the future treatment of ischaemic diseases. � 2013 The Authors. Published by Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.en_US
dc.description.natureFinalen_US
dc.identifier.doi10.1111/jcmm.12051
dc.identifier.epage692
dc.identifier.issn15821838
dc.identifier.issue5
dc.identifier.pmid23551495
dc.identifier.scopus2-s2.0-84878364314
dc.identifier.spage681
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84878364314&doi=10.1111%2fjcmm.12051&partnerID=40&md5=76873ec3fbc57ab9aede85f801b8d40a
dc.identifier.urihttps://oarep.usim.edu.my/handle/123456789/9994
dc.identifier.volume17
dc.languageEnglish
dc.language.isoen_USen_US
dc.relation.ispartofOpen Accessen_US
dc.relation.ispartofJournal of Cellular and Molecular Medicine
dc.sourceScopus
dc.subjectFetal stem cellsen_US
dc.subjectIschemic diseaseen_US
dc.subjectPro-angiogenicen_US
dc.subjectQuantitative PCRen_US
dc.subjectVascularen_US
dc.titlePro-angiogenic potential of human chorion-derived stem cells: In vitro and in vivo evaluationen_US
dc.title.alternativeJ. Cell. Mol. Med.en_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pro-angiogenic potential of human chorion-derived stem cells; In vitro and in vivo evaluation.pdf
Size:
2.23 MB
Format:
Adobe Portable Document Format

Collections